We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA to Soon Reveal New DMF Screening Process Under GDUFA
FDA to Soon Reveal New DMF Screening Process Under GDUFA
September 25, 2012
Next month, the FDA will begin revealing its criteria for initial completeness tests for Type II active pharmaceutical ingredient (API) drug master files (DMF), an FDA official says.